DS9051b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DS9051b, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer [Phase 1]